Abstract
The amorphous complex of 2-hydroxypropyl-β-cyclodextrin (HP-β-CyD) with an oral hypoglycemic agent, chlorpropamide (CPM), in a molar ratio of 1:1 was prepared by the spray-drying method. The effects of storage (temperature and humidity) and moulding pressure on the polymorphic transition of CPM in HP-β-CyD matrix were investigated, in comparison with those of the CPM polymorphs, Form A (stable form) and Form C (metastable form). The formation of an amorphous complex of CPM with HP-β-CyD was confirmed by powder X-ray diffractometry and differential scanning calorimetry. During storage at various temperature and humidity conditions, the metastable Form C of CPM converted to the stable Form A, where the conversion proceeded according to the Jander equation with an activation energy of 51 kJ/mol (25–60–°C) and a reaction-order of 1.55 with respect to water content (relative humidity (RH) 20–75%). No polymorphic transition of Form A crystals was observed under the experimental conditions. In the case of the amorphous HP-β-CyD complex, Form C crystals were slowly produced, but the further conversion of the resulting Form C to Form A was markedly suppressed in HP-β-CyD matrix. Upon compression (2000kg/cm2), Forms A and C were converted to amorphous CPM in a major portion and Forms C and A, respectively, in a minor portion. The polymorphic transition behavior was clearly reflected in the dissolution rate of CPM, i.e., (1) the dissolution rate was in the order of HP-β-CyD complex (Form C) Form A, and (2) the dissolution rate of Forms A and C after the compression increased because of the conversion to amorphous state, while the complex maintained the fast dissolving property even after the compression. The results indicated that HP-β-CyD is useful not only for converting crystalline CPM to an amorphous substance, but also for maintaining the metastable form with fast dissolution rate, Form C, over a long period.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
J. Haleblian and W. McCrone: J. Pharm. Sci. 58, 911 (1969).
H.G. Brittain, S.J. Bogdanowich, D.E. Bugay, J.D. Vincentis, G. Lewen, and A.W. Newman: Pharm. Res. 8, 963 (1991).
K. Uekama, F. Hirayama, and T. Irie: Chem. Rev. 98, 2045 (1998).
K. Uekama (Theme Editor): Adv. Drug Deliv. Rev. 36, 1 (1999).
E.Albers and B.W. Müller: CRC Crit. Rev. Ther. Drug Carrier Syst. 12, 311 (1995).
J. Horsky and J. Pitha: J. Pharm. Sci. 85, 96 (1996).
T.Loftsson and M.E. Brewster: J. Pharm. Sci. 85, 1017 (1996).
K. Kimura, F. Hirayama, H. Arima, and K. Uekama: Pharm. Res. 16, 1729 (1999).
K.Kimura, F. Hirayama, H. Arima, and K. Uekama: Chem. Pharm. Bull. 48, 646 (2000).
H.Ueda, N. Nambu, and T. Nagai: Chem. Pharm. Bull. 32, 244 (1984).
M.Otsuka, T. Matsumoto, and N. Kaneniwa: J. Pharm. Pharmacol. 41, 665 (1989).
H. Hyqvisty: Int. J. Pharm. Technol. Prod. Mfr. 4, 47 (1983).
H. Nogami, T. Nagai, and Y. Yotsuyanagi: Chem. Pharm. Bull. 17, 499 (1969).
J.D. Hancock and J.H. Sharp: J. Am. Ceram. Soc. 55, 74 (1972).
K. Kimura, F. Hirayama, and K. Uekama: J. Pharm. Sci. 88, 385 (1999).
J.T. Carstensen, E.S. Aron, D.C. Spera, and J.J. Vance: J. Pharm. Sci. 55, 561 (1966).
Ostwald: Z. Physik. Chem. 22, 209 (1897).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sonoda, Y., Hirayama, F., Arima, H. et al. Effects of 2-Hydroxypropyl-b-cyclodextrin on Polymorphic Transition of Chlorpropamide in Various Conditions: Temperature, Humidity and Moulding Pressure. Journal of Inclusion Phenomena 50, 73–77 (2004). https://doi.org/10.1007/s10847-004-8842-8
Issue Date:
DOI: https://doi.org/10.1007/s10847-004-8842-8